Evidence map›Paper›PMID 18952047›Full record

ArticleArchives of biochemistry and biophysics2009

Effect of double bond geometry in sphingosine base on the antioxidant function of sphingomyelin.

Papasani V Subbaiah, Debajit Sircar, Ravi S Lankalapalli, Robert Bittman

Abstract read
In one paragraph

Article in Archives of biochemistry and biophysics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Papasani V SubbaiahDepartment of Medicine, Section of Endocrinology and Metabolism, University of Illinois at Chicago, 1819 West Polk Street, Chicago, IL 60612, USA. psubbaia@uic.edu
Debajit Sircar
Ravi S Lankalapalli
Robert Bittman
Queens College, CUNY · USUniversity of Illinois Chicago · US

Funding

ROLE OF SPHINGOMYELIN IN LIPOPROTEIN METABOLISMR01HL068585 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2002 to 2012
$3.3M
Synthesis of Novel Bioactive Sphingolipids as a ResourceR24HL083187 · NHLBI · QUEENS COLLEGE · PI BITTMAN, ROBERT · 2006 to 2013
$2.5M
Role of Sphingomyelin in Lipoprotein MetabolismR56HL068585 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SUBBAIAH, PAPASANI V · 2008 to 2008
$393k
NHLBI NIH HHS HL 083187NHLBI NIH HHS HL 68585NHLBI NIH HHS R01 HL068585NHLBI NIH HHS R24 HL083187NHLBI NIH HHS R56 HL068585
6 · The paper itself

Abstract

We previously showed that sphingomyelin (SM) inhibits peroxidation of phosphatidylcholine (PC) and cholesterol. Since SM uniquely has a trans unsaturation in its sphingosine base, we investigated whether this feature is important for its antioxidant function. Substitution of the natural trans Delta(4)-double bond with a cis double bond (cis-SM), however, increased SM's ability to inhibit Cu(2+)-mediated 16:0-18:2 PC oxidation by up to eightfold. Dihydro-SM, which lacks the double bond, was equally effective as trans-SM. In contrast to its effect in the sphingosine base, the presence of a cis double bond in the N-acyl group of trans-SM was not protective. cis-SM also inhibited the oxidation of cholesterol by FeSO_(4)/ascorbate more efficiently than the trans isomer. The enhanced protective effect of cis-SM is selective for metal ion-promoted oxidation, and appears to arise from a decrease in the effective concentration of metal ions. These studies show that the trans double bond of SM is not essential for its antioxidant effects.

Indexed as

AntioxidantsAscorbic AcidCations, DivalentCholesterolCopperFerrous CompoundsLipid PeroxidationOxidation-ReductionPhosphatidylcholinesSphingomyelinsSphingosineStereoisomerismAntioxidantsAscorbic AcidCations, DivalentCholesterolCopperFerrous Compoundsferrous sulfatePhosphatidylcholinesSphingomyelinsSphingosine

Identifiers

PMID18952047
PMCPMC2636625
OpenAlexW2167259232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.